2,6-Bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)pyridine, 98% 99%ee, 250mg

4-Bromo-3-methoxypyridine, 97%, 1g

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 97%, 5g

NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(T)5g

1-(3-Chloro-5-fluoro-2-hydroxyphenyl)ethan-1-one, 95%, 5g

Piperidine-1-sulfonyl chloride, 97.0%, 25g

1,1,3,3,5,5,7,7-Octamethyltetrasiloxane, 95%, 1g

(1R,5S)-endo-8-Benzyl-8-azabicyclo[3.2.1]octan-3-amine, 95.0%, 100mg

3-Hydroxypropionic acid, 30% in water, 95.0%, 5g

4-[(E)-4-Pyridinylazo]pyridine, 97%, 1g

Cyclopropanecarboxamide, 95.0%, 25g

6-(4-Bromophenoxy)pyridin-3-amine, 97%, 100mg

(R)-1-(o-Tolyl)butan-1-amine hydrochloride, 95.0%, 100mg